“…Hemoglobin- (Hb-) based oxygen (O 2 ) carriers (HBOCs) are a promising class of red blood cell (RBC) substitute currently undergoing development as an O 2 therapeutic. Currently, many methods of HBOC preparation are being explored, including protein polymerization, − surface conjugation with polyethylene glycol, , liposome encapsulation, − microparticle formulation, , and the recombinant expression of genetically modified Hb . Because of the low cost of polymerization reagents, the polymerization of Hb with the chemical cross-linker glutaraldehyde to form polymerized Hb (PolyHb) is the most common strategy for manufacturing HBOCs for use as RBC substitutes in transfusion medicine.…”